Pre-made Alsevalimab benchmark antibody ( Whole mAb, anti-VTCN1 therapeutic antibody, Anti-B7-H4/B7H4/B7S1/B7X/B7h.5/PRO1291/VCTN1 Antibody) for drug discovery and mechanism of action (MOA) research

Cat No.: GMP-Bios-ab-019

Pre-Made Alsevalimab biosimilar, Whole mAb, Anti-VTCN1 Antibody: Anti-B7-H4/B7H4/B7S1/B7X/B7h.5/PRO1291/VCTN1 therapeutic antibody is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.



Order information


* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry

Catalog No. Package List Price(In USD) Discount off Discount Price
GMP-Bios-ab-019-1mg 1mg 3090 30% 2163

Size: 1mg | 10mg | 100mg



Description

Products Name (INN Index) Pre-Made Alsevalimab biosimilar, Whole mAb, Anti-VTCN1 Antibody: Anti-B7-H4/B7H4/B7S1/B7X/B7h.5/PRO1291/VCTN1 therapeutic antibody
INN Name Alsevalimab
TargetVTCN1
FormatWhole mAb
Derivation
Species ReactivityHuman
CH1 IsotypeIgG1
VD LCKappa
Highest_Clin_Trial (Jan '20)Phase-I
Est. StatusActive
100% SI StructureNone
99% SI StructureNone
95-98% SI StructureNone
Year Proposed2019
Year Recommended2020
CompaniesFive Prime Therapeutics
Conditions Approvedna
Conditions ActiveSolid tumours
Conditions Discontinuedna
Development Techna